BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Intradigm Corporation 

12115 Parklawn Drive, Suite K

Rockville  Maryland  20852  U.S.A.
Phone: 301-984-0185 Fax: 301-984-0186


SEARCH JOBS



Segment
Genomics





 Company News
Silence Therapeutics plc Announces Completion Of Merger With Intradigm Corporation And Issue Of New Shares 1/6/2010 2:12:08 PM    More...
Silence Therapeutics plc Agrees to Buy Intradigm Corporation in a Share-Swap Deal Worth $26 Million 12/16/2009 6:29:03 AM    More...
Intradigm Corporation Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 5/19/2009 11:25:55 AM    More...
Intradigm Corporation Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 3/17/2009 10:51:47 AM    More...
Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive Officer 1/7/2009 6:50:27 AM    More...
Intradigm Corporation Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics Zamore Patent Covers Methods for Enhancing RNAi Structural Features and Strengthens Intradigm's Competitive Position 12/2/2008 9:34:03 AM    More...
Intradigm Corporation Raises $18.5 Million in Series B Financing 10/2/2008 6:34:40 AM    More...
Intradigm Corporation Announces Allowance of Key RNA Interference (RNAi) Patent 6/17/2008 11:13:28 AM    More...
Study Shows Intradigm Corporation's RNAi Nanoplex Technology To Be Effective 4/14/2008 10:27:57 AM    More...
Intradigm Corporation Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School 4/9/2008 8:36:49 AM    More...
123

//-->